Phase 1 dose-escalation study to be conducted at clinical sites in the U.S., the UK, Australia, and the Philippines
The decision is based on the outcome of a prespecified interim analysis of the Phase 3 AMEERA-5 trial
The Trial, the first of its kind in Israel, recently obtained approval from the Israeli Ministry of Health and is preparing for participant recruitment.
WCK 5222 is a Super-drug which is entirely a new class of antibiotic known as "?-lactam ENHANCER".
Biopharma and CROs to benefit from simplified access to global research sites
The NTM-001 Phase I clinical study is expected to be completed by the end of 2022
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV Infection
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
Doctors will study for a Master of Surgery or Master of Medicine degree at Edge Hill University.
Subscribe To Our Newsletter & Stay Updated
